Auspex Pharmaceuticals' P2P Acquisition

Auspex Pharmaceuticals raised a round of funding on March 30, 2015. Investors include Teva Pharmaceuticals.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' P2P Acquisition: